275 related articles for article (PubMed ID: 24890047)
1. Endogenous androgens and risk of epithelial invasive ovarian cancer by tumor characteristics in the European Prospective Investigation into Cancer and Nutrition.
Ose J; Fortner RT; Rinaldi S; Schock H; Overvad K; Tjonneland A; Hansen L; Dossus L; Fournier A; Baglietto L; Romieu I; Kuhn E; Boeing H; Trichopoulou A; Lagiou P; Trichopoulos D; Palli D; Masala G; Sieri S; Tumino R; Sacerdote C; Mattiello A; Ramon Quiros J; Obón-Santacana M; Larrañaga N; Chirlaque MD; Sánchez MJ; Barricarte A; Peeters PH; Bueno-de-Mesquita HB; Onland-Moret NC; Brändstedt J; Lundin E; Idahl A; Weiderpass E; Gram IT; Lund E; Kaw KT; Travis RC; Merritt MA; Gunther MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Jan; 136(2):399-410. PubMed ID: 24890047
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory Markers and Risk of Epithelial Ovarian Cancer by Tumor Subtypes: The EPIC Cohort.
Ose J; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopolou A; Benetou V; Lagiou P; Masala G; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Weiderpass E; Gram IT; Sánchez S; Obon-Santacana M; Sànchez-Pérez MJ; Larrañaga N; Castaño JM; Ardanaz E; Brändstedt J; Lundin E; Idahl A; Travis RC; Khaw KT; Rinaldi S; Romieu I; Merritt MA; Gunter MJ; Riboli E; Kaaks R; Fortner RT
Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):951-61. PubMed ID: 25855626
[TBL] [Abstract][Full Text] [Related]
3. Reproductive and hormone-related risk factors for epithelial ovarian cancer by histologic pathways, invasiveness and histologic subtypes: Results from the EPIC cohort.
Fortner RT; Ose J; Merritt MA; Schock H; Tjønneland A; Hansen L; Overvad K; Dossus L; Clavel-Chapelon F; Baglietto L; Boeing H; Trichopoulou A; Benetou V; Lagiou P; Agnoli C; Mattiello A; Masala G; Tumino R; Sacerdote C; Bueno-de-Mesquita HB; Onland-Moret NC; Peeters PH; Weiderpass E; Torhild Gram I; Duell EJ; Larrañaga N; Ardanaz E; Sánchez MJ; Chirlaque MD; Brändstedt J; Idahl A; Lundin E; Khaw KT; Wareham N; Travis RC; Rinaldi S; Romieu I; Gunter MJ; Riboli E; Kaaks R
Int J Cancer; 2015 Sep; 137(5):1196-208. PubMed ID: 25656413
[TBL] [Abstract][Full Text] [Related]
4. Androgens Are Differentially Associated with Ovarian Cancer Subtypes in the Ovarian Cancer Cohort Consortium.
Ose J; Poole EM; Schock H; Lehtinen M; Arslan AA; Zeleniuch-Jacquotte A; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Dossus L; Trichopoulou A; Masala G; Onland-Moret NC; Weiderpass E; Duell EJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Trabert B; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Res; 2017 Jul; 77(14):3951-3960. PubMed ID: 28381542
[TBL] [Abstract][Full Text] [Related]
5. Early pregnancy sex steroids and maternal risk of epithelial ovarian cancer.
Schock H; Surcel HM; Zeleniuch-Jacquotte A; Grankvist K; Lakso HÅ; Fortner RT; Kaaks R; Pukkala E; Lehtinen M; Toniolo P; Lundin E
Endocr Relat Cancer; 2014; 21(6):831-44. PubMed ID: 25270324
[TBL] [Abstract][Full Text] [Related]
6. Endogenous androgens and risk of epithelial ovarian cancer: results from the European Prospective Investigation into Cancer and Nutrition (EPIC).
Rinaldi S; Dossus L; Lukanova A; Peeters PH; Allen NE; Key T; Bingham S; Khaw KT; Trichopoulos D; Trichopoulou A; Oikonomou E; Pera G; Larrañaga N; Martinez-Garcia C; Ardanaz E; Quirós JR; Tormo MJ; Tjønneland A; Olsen A; Overvad K; Chang-Claude J; Linseisen J; Schulz M; Boeing H; van Gils CH; Bueno-de-Mesquita BH; Pala V; Palli D; Panico S; Tumino R; Vineis P; Clavel-Chapelon F; Mesrine S; Boutron-Ruault MC; Lundin E; Agren A; Berglund G; Manjer J; Kumle M; Lund E; Slimani N; Saracci R; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):23-9. PubMed ID: 17220328
[TBL] [Abstract][Full Text] [Related]
7. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
[TBL] [Abstract][Full Text] [Related]
8. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium.
Ose J; Schock H; Poole EM; Lehtinen M; Visvanathan K; Helzlsouer K; Buring JE; Lee IM; Tjønneland A; Boutron-Ruault MC; Trichopoulou A; Mattiello A; Onland-Moret NC; Weiderpass E; Sánchez MJ; Idahl A; Travis RC; Rinaldi S; Merritt MA; Wentzensen N; Tworoger SS; Kaaks R; Fortner RT
Cancer Causes Control; 2017 May; 28(5):429-435. PubMed ID: 28205047
[TBL] [Abstract][Full Text] [Related]
9. Activated leukocyte cell adhesion molecule soluble form: a potential biomarker of epithelial ovarian cancer is increased in type II tumors.
Carbotti G; Orengo AM; Mezzanzanica D; Bagnoli M; Brizzolara A; Emionite L; Puppo A; Centurioni MG; Bruzzone M; Marroni P; Rossello A; Canevari S; Ferrini S; Fabbi M
Int J Cancer; 2013 Jun; 132(11):2597-605. PubMed ID: 23169448
[TBL] [Abstract][Full Text] [Related]
10. Acrylamide and Glycidamide Hemoglobin Adducts and Epithelial Ovarian Cancer: A Nested Case-Control Study in Nonsmoking Postmenopausal Women from the EPIC Cohort.
Obón-Santacana M; Lujan-Barroso L; Travis RC; Freisling H; Ferrari P; Severi G; Baglietto L; Boutron-Ruault MC; Fortner RT; Ose J; Boeing H; Menéndez V; Sánchez-Cantalejo E; Chamosa S; Castaño JM; Ardanaz E; Khaw KT; Wareham N; Merritt MA; Gunter MJ; Trichopoulou A; Papatesta EM; Klinaki E; Saieva C; Tagliabue G; Tumino R; Sacerdote C; Mattiello A; Bueno-de-Mesquita HB; Peeters PH; Onland-Moret NC; Idahl A; Lundin E; Weiderpass E; Vesper HW; Riboli E; Duell EJ
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):127-34. PubMed ID: 26598536
[TBL] [Abstract][Full Text] [Related]
11. Increase of fallopian tube and decrease of ovarian carcinoma: fact or fake?
Höhn AK; Klagges S; Gläser A; Taubenheim S; Dornhöfer N; Einenkel J; Hiller GGR; Brambs CE; Horn LC
J Cancer Res Clin Oncol; 2021 Mar; 147(3):911-925. PubMed ID: 32915262
[TBL] [Abstract][Full Text] [Related]
12. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
13. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
[TBL] [Abstract][Full Text] [Related]
14. Validation of Revised FIGO Staging Classification for Cancer of the Ovary, Fallopian Tube, and Peritoneum Based on a Single Histological Type.
Toptas T; Pestereli E; Erol O; Bozkurt S; Erdogan G; Simsek T
Int J Gynecol Cancer; 2016 Jul; 26(6):1012-9. PubMed ID: 27206284
[TBL] [Abstract][Full Text] [Related]
15. The expression of asparaginyl endopeptidase promotes growth potential in epithelial ovarian cancer.
Zhu Q; Tang M; Wang X
Cancer Biol Ther; 2017 Apr; 18(4):222-228. PubMed ID: 28278071
[TBL] [Abstract][Full Text] [Related]
16. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium.
Wentzensen N; Poole EM; Trabert B; White E; Arslan AA; Patel AV; Setiawan VW; Visvanathan K; Weiderpass E; Adami HO; Black A; Bernstein L; Brinton LA; Buring J; Butler LM; Chamosa S; Clendenen TV; Dossus L; Fortner R; Gapstur SM; Gaudet MM; Gram IT; Hartge P; Hoffman-Bolton J; Idahl A; Jones M; Kaaks R; Kirsh V; Koh WP; Lacey JV; Lee IM; Lundin E; Merritt MA; Onland-Moret NC; Peters U; Poynter JN; Rinaldi S; Robien K; Rohan T; Sandler DP; Schairer C; Schouten LJ; Sjöholm LK; Sieri S; Swerdlow A; Tjonneland A; Travis R; Trichopoulou A; van den Brandt PA; Wilkens L; Wolk A; Yang HP; Zeleniuch-Jacquotte A; Tworoger SS
J Clin Oncol; 2016 Aug; 34(24):2888-98. PubMed ID: 27325851
[TBL] [Abstract][Full Text] [Related]
17. Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study.
Elzarkaa AA; Sabaa BE; Abdelkhalik D; Mansour H; Melis M; Shaalan W; Farouk M; Malik E; Soliman AA
J Cancer Res Clin Oncol; 2016 May; 142(5):949-58. PubMed ID: 26762850
[TBL] [Abstract][Full Text] [Related]
18. Extrauterine Pelvic Serous Carcinomas: Current Update on Pathology and Cross-sectional Imaging Findings.
Katabathina VS; Amanullah FS; Menias CO; Chen MM; Valente PT; Chintapalli KN; Prasad SR
Radiographics; 2016; 36(3):918-32. PubMed ID: 27163599
[TBL] [Abstract][Full Text] [Related]
19. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
20. Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases.
Maeda D; Ota S; Takazawa Y; Ohashi K; Mori M; Imamura T; Nakagawa S; Yano T; Taketani Y; Fukayama M
Virchows Arch; 2010 Nov; 457(5):597-608. PubMed ID: 20872013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
